Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?
about
Evidence-based kernels: fundamental units of behavioral influenceEvolving the future: toward a science of intentional changeThe use of financial incentives in promoting smoking cessationContingency Management and Deliberative Decision-Making ProcessesContingency management delivered by community therapists in outpatient settings.A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disordersA public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence.Group-based randomized trial of contingencies for health and abstinence in HIV patientsFacilitating the adoption of contingency management for the treatment of substance use disorders.Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.Competing neurobehavioral decision systems theory of cocaine addiction: From mechanisms to therapeutic opportunities.Psychometric properties of the contingency management competence scale.Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen?Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chancePrize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation.Prize-based contingency management for the treatment of substance abusers: a meta-analysisOrganizational factors associated with the use of contingency management in publicly funded substance abuse treatment centersLost in translation? Moving contingency management and cognitive behavioral therapy into clinical practiceRationale for Using Exercise in the Treatment of Stimulant Use Disorders.Standard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.Acceptability of contingency management among clinicians and clients within a co-occurring mental health and substance use treatment programAcceptability of drug testing in an outpatient substance abuse program for adolescents.Behavioral Interventions for Individuals Dually-Diagnosed with a Severe Mental Illness and a Substance Use Disorder.Behavioral vaccines and evidence-based kernels: nonpharmaceutical approaches for the prevention of mental, emotional, and behavioral disorders.Clinic variation in the cost-effectiveness of contingency managementCost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency managementContingency management is especially efficacious in engendering long durations of abstinence in patients with sexual abuse historiesCost evaluation of evidence-based treatmentsInteraction effects of age and contingency management treatments in cocaine-dependent outpatients.Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana useStimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trialIdentifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaireInitial abstinence status and contingency management treatment outcomes: does race matter?Cost-effectiveness of childcare discounts on parent participation in preventive parent training in low-income communities.Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes.Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.Abstinence rates following behavioral treatments for marijuana dependence.
P2860
Q24656982-3747C263-20AF-4188-9766-F46C74DB77BBQ26864880-630D81B4-8DCE-4F18-835B-4561292FAD94Q26992095-B9657B73-3BAB-480C-AE6D-5CD5B5453B2FQ28082893-97DDD05A-BF1D-474B-A37F-F8CD30D613E1Q30506043-4B947E09-B6A8-43ED-8961-2A727E8020F6Q30537387-7B344DA9-0AB0-416F-8845-C1D28DE6F4A5Q33254470-164E4415-736F-4279-A5E6-217890AAF576Q33618807-F95F16F9-60B1-4ADC-B53A-9700C04BF20EQ33787169-719DFF8A-0F76-454C-BE04-73110861113DQ33836751-E880099E-C10C-409A-B955-BC3480B3FBC5Q33865481-B57BA9B4-9F8F-47AC-80AE-5C91AAD05A8EQ33872287-5BF28AF2-C104-4383-AA33-D756D7B3D274Q33938769-5E110ED7-F0BA-4415-81E0-48E17059CD93Q33949888-3919AFD0-8B08-4BB5-B940-0A95A4B4F804Q34018867-46D6B05D-42D3-4244-9326-9A85C80B66A3Q34098382-5BF55577-EC6E-4DE6-90F2-2276D67DA8F3Q34117598-978C97EE-9ECA-4A10-B467-14F0CDFB3AFAQ34372309-83A661EF-90CF-4851-B9E0-AD1BF481D4BCQ34384706-B94840CE-A8A3-459B-925B-F0D0E552752AQ34389080-CA0D0DA2-D2F6-4275-92A5-93E2F1C1BD62Q34427065-DE24CD7D-5200-419C-8A48-BAD89A4D507EQ34437363-8441C050-F06F-4FD4-84C7-925456671349Q34598444-CBC0781A-D931-4542-B1D9-D2D3FB96F6F4Q34644290-26D73A65-0179-4426-B09F-F89263AF0FCEQ34713369-0B47B6F0-4BA2-4544-8165-E65977DD8C5FQ34725155-F52A4697-E788-4A13-99E6-9B9D4F1A8F71Q34769497-B0E5541B-2AC7-4BC3-9E46-5653715B61F6Q34773845-9F9D092C-F3A9-4C54-8266-B30B85681BE6Q34936932-E88DFC9B-84C3-4044-9567-02ED4F051530Q35046761-B2DC033D-67B4-4298-97F1-7B2256016168Q35059940-66C7C6C1-8201-4992-BDB2-C66CD6616A40Q35062387-A5633215-550B-482B-BEA3-EBD462EB9D80Q35126834-B06E41E7-58F5-4CFA-95C1-91EB2E56F184Q35318875-F40AD210-6FC4-48A5-9A10-2201FBC4D7CFQ35626993-99F61840-4E15-4BE8-85CF-FBAC0862EAB6Q35655648-1FB1EB31-D63C-4591-9BD6-DFC12198F579Q35660427-3A93E680-F750-471F-A945-06F2A138404DQ35781994-5C0BF34F-1593-49D0-AF0C-2873D30DC2BDQ35851482-6C36AF8E-23E4-4C5D-950F-E220FAEFFCC1Q35862851-32E65EFF-178E-4FF1-9AB7-950FD6C617BC
P2860
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prize reinforcement contingenc ...... low can we go, and with whom?
@en
Prize reinforcement contingenc ...... low can we go, and with whom?
@nl
type
label
Prize reinforcement contingenc ...... low can we go, and with whom?
@en
Prize reinforcement contingenc ...... low can we go, and with whom?
@nl
prefLabel
Prize reinforcement contingenc ...... low can we go, and with whom?
@en
Prize reinforcement contingenc ...... low can we go, and with whom?
@nl
P2093
P2860
P1433
P1476
Prize reinforcement contingenc ...... low can we go, and with whom?
@en
P2093
Bruce J Rounsaville
Charla Nich
Jacqueline Tedford
Mark Austin
Nancy M Petry
P2860
P304
P356
10.1111/J.1360-0443.2003.00642.X
P407
P577
2004-03-01T00:00:00Z